Join to View Full Profile
35 Park StreetNew Haven, CT 06510
Phone+1 617-632-6876
Fax+1 617-632-1930
Dr. Winer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1989
Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987- Yale-New Haven Medical CenterInternship, Internal Medicine, 1983 - 1984
Yale School of MedicineClass of 1983
Certifications & Licensure
ME State Medical License Current
CT State Medical License 2021 - 2026
MA State Medical License 1997 - 2023
NC State Medical License 1987 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
Clinical Trials
- Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases Start of enrollment: 2004 Oct 01
- Educational Interventions for Patients With DCIS Start of enrollment: 2003 May 01
- Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer Start of enrollment: 2003 Dec 01
Publications & Presentations
PubMed
- Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.Amin H Nassar, Elias Bou Farhat, Hassan Abushukair, Michel Alchoueriy, Samer Salem
Journal of the National Cancer Institute. 2026-04-01 - TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations inor Somatic...Nadine M Tung, Mark E Robson, Tianyu Li, Rita Nanda, Payal D Shah
Journal of Clinical Oncology. 2026-03-10 - The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy.Andrea H Bild, Michelle C Sangar, Jasmine A McQuerry, Trey Ideker, Scott Kopetz
Cancer Cell. 2026-03-09
Journal Articles
- Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast CancerEric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
- Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast CancerSara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
- Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 StudyM C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
Lectures
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/11/2013
- 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS)UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/12/2012
Press Mentions
Smilow Cancer Hospital at Greenwich Hospital Celebrates Beginning of Construction with Transformation Kickoff CeremonyApril 9th, 2026- Community Collaboration Supports Prostate Cancer Rally in New HavenJanuary 5th, 2026
- Extended Survival for Advanced Breast Cancer Patients Attributed to Breakthroughs in Treatment and CareNovember 6th, 2025
Grant Support
- Cancer Center Support GrantYALE UNIVERSITY1997–2029
- Cancer Center Support GrantYALE UNIVERSITY1997–2029
- Cancer Center Support GrantYALE UNIVERSITY1997–2029
- Cancer Center Support GrantYALE UNIVERSITY1997–2029
- Clinical Studies CoreNational Cancer Institute2008–2009
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
